Oxford textbook of oncology /

Saved in:
Bibliographic Details
Imprint:Oxford ; New York : Oxford University Press, 1995.
Description:2 v. (xxiii, 2481, 124 p.) : ill. ; 29 cm.
Language:English
Series:Oxford medical publications.
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/2384912
Hidden Bibliographic Details
Varying Form of Title:Textbook of oncology
Other authors / contributors:Peckham, M. J. (Michael J.)
Pinedo, H. M.
Veronesi, Umberto.
ISBN:0192616854 (hbk. : set)
0192626639 (vol. 1)
0192626647 (vol. 2)
Notes:Includes bibliographical references and indexes.
Table of Contents:
  • Section I. The Biology of Cancer
  • 1.1. The Growth of Human Tumors
  • 1.2. Polypeptide and Neuropeptide Growth Factors: Signalling Pathways and Role in Cancer
  • 1.3. Differentiation and Cancer
  • 1.4. Chromosomes and Cancer
  • 1.5. Genetics and Familial Cancer
  • 1.6. Oncogents
  • 1.7. The Cell Mediated Response to Tumors
  • 1.8. Cytokines
  • 1.9. Cancer Metastasis
  • 1.10. Monoclonal Antibodies
  • Section 2. Etiology, Epidemiology and Prevention of Cancer
  • 2.1. Cell and Molecular Mechanisms in Chemical Carcinogenesis
  • 2.2. Viral Carcionogenesis
  • 2.3. Cellular and Molecular Mechanisms in Radiation Carcinogenesis
  • 2.4. The Cancer Registry: Organization and Function
  • 2.5. Etiological Leads
  • 2.8. Prospects for TUmor Chemoprevention
  • 2.9. Practical Applications of the New Cancer Genetics
  • 2.10. Evaluation of Screening for Cancer
  • 2.11. Cancer Epidemiology and Prevention
  • Section 3. Diagnosis and Investigative Procedures
  • 3.1. Histopathological Classification and Typing of Solid Tumors
  • 3.2. New Techniques in Pathology and Their Application in Diagnosis and Studies of Tumor Biology
  • 3.3. Cytology
  • 3.4. Flow Cytometry
  • 3.5. Clinical Approaches to Precancerous States
  • 3.6. The Role of Radiological Imaging in the Management of Cancer
  • 3.7. Positron Emission Tomography
  • 3.8. Magnetic Resonance in Oncology
  • 3.9. Interventional Radiology: Percutaneous Tissue Sampling Guided by Imaging
  • 3.10. Ultrasonic Scanning
  • 3.11. Circulating Tumor Markers
  • 3.12. Nuclear Medicine Procedures
  • Section 4. The Scientific Basis of Cancer Treatment
  • 4.1. Chemotherapy: General Aspects
  • 4.2. Biomolecular Structure and Rational Drug Design
  • 4.3. Protein Modelling
  • 4.4. Structure-activity Relationships of Anticancer Agents
  • 4.5. New Drug Development
  • 4.6. Alkylating Agents and Related Drugs
  • 4.7. Antitumor Antibiotics
  • 4.8. Antimetabolitess
  • 4.9. Cisplatin and Analogues: Discovery, Mechanism of Action and Clinical Pharmacology
  • 4.10. Podophyllotoxins
  • 4.11. Vinca Alkaloids: Cellular Pharmacology and Clinical Pharmakinetics
  • 4.12. New and Miscellaneous Anticancer Drugs: Future Development of Drug Design
  • 4.13. Drug Resistance
  • 4.14. High-dose Chemotherapy and Autologous Bone-marrow Rescue
  • 4.15. Clinical Uses of Hemopoietic Growth Factors
  • 4.16. The Basis of Hormonal Therapy of Cancer
  • 4.17. Targeted Therapy with Microspheress and Other Carrier Systems
  • 4.18. Monoclonal Antibody Targeting
  • 4.19. The Biological Basis of Radiotherapy
  • 4.20. Current Practice of Radiotherapy: Physical Basis
  • 4.21. External Beam Radiation Therapy Including Conformational Therapy
  • 4.22. Interstitial Radiation Therapy
  • 4.23. Intracavitary Therapy
  • 4.24. Total Body Irradiation
  • 4.25. Intraoperative Radiotherapy - An Investigatinoal Approach to Cancer Treatment
  • 4.26. Particle Radiotherapy
  • 4.27. Targeted Radiotherapy
  • 4.28. Hypoxia - Selective Bioreductive Drugs
  • 4.29. Clinical Fractionation Studies
  • 4.30. Combined Chemotherapy and Radiotherapy
  • 4.31. Hyperthermia
  • 4.32. Photodynamic Therapy
  • 4.33. Lasers in Oncology
  • 4.34. Principles of Pharmacokinetics, Principles of Pharmacokinetics
  • Section 5. Progress in Cancer Treatment
  • 5.1. Surgery Radiotherapy and Chemotherapy
  • t(i). Achievement and Obstacles to Progress in Cancer Surgery
  • t(ii). Radiotherapy
  • t(iii). Achievement of Chemotherapy and Obstacles to Further Progress
  • 5.2. Staging Classifications
  • Section 6. Skin Cancer and Tumors of the Head and Neck
  • 6.1. Skin Cancer Other than Melanoma
  • 6.2. Cutaneous Melanoma
  • 6.3. The Eye and Orbit
  • (i). Melanoma of the Eye and Orbit
  • (ii). Tumors of the Orbit
  • 6.4. Salivary Tumors
  • 6.5. Carcinoma of the Nasal Cavity and Paranasal Sinuses
  • 6.7. Tumors of the Oral Cavity
  • (i). Epidemiology and Clinicopathological Aspects of Premalignant Lesions. I. Van der Waal
  • (ii). The Roles of Surgery in the Treatment of Tumors of the Oral Cavity
  • (iii). The Role of Radiotherapy in the Treatment of Tumors of the Oral Cavity. A. Gerbaulet
  • 6.8. Tumors of the Oropharynx
  • 6.9. Tumors of the Hypopharynx
  • 6.10. Tumors of the Larynx
  • 6.11. Uncommon Tumors of the Head and Neck Region
  • 6.12. Carcinoma of the External Auditory Meatus and Middle Ear
  • 6.13. Management of Cervical Lymph Nodes
  • 6.14. Chemotherapy in Conjunction with Radiotherapy and/or Surgery in Head and Neck Cancer
  • Section 7. Gastrointestinal Tumors
  • 7.1. Malignancies of the Oesophagus
  • 7.2. Cancer of the Stomach
  • 7.3. Malignancies of the Small Bowel
  • 7.4. Colorectal Tumors
  • 7.5. Radical Radiotherapy of Cancer of the Rectum and Anus
  • 7.6. Tumors of the Panceras
  • 7.7. Liver Tumors
  • 7.8. Tumors of the Biliary Tract
  • Section 8. Breast Cancer U. Veronesi
  • Section 9. Gynecological Malignancy
  • 9.1. Carcinoma of the Ovary
  • 9.2. Ovarian Germ-Cell and Other Rare Ovarian Tumors
  • 9.3. Carcinoma of the Cervix
  • 9.4. Gestational Trophoblastic Tumors
  • 9.5. Carcionma of the Vagina
  • 9.6. Carcinoma of the Vulva and its Putative Precursors
  • 9.7. Sarcoma and Melanoma of the Female Genital System
  • 9.8. Tumors of the Endometrium and Adnexa
  • Section 10. Urological Cancer
  • 10.1. Testicular Tumors
  • 10.2. Extragonadal Germ-Cell Tumors
  • 10.3. Tumors of the Penis
  • 10.4. Bladder Cancer
  • 10.5. Tumors of the Kidney (Other than Nephroblastoma)
  • 10.6. Tumors of the Prostate
  • Section 11. Thoracic Tumors
  • 11.1. Tumors of the Trachea and Lung
  • 11.2. Mesothelioma
  • 11.3. Thymic Tumors with Myasthemia Gravis or Bone Marrow Dyscrasias
  • 11.4. Other Thymic Tumors
  • 11.5. Surgical Resection of Pulmonary Metastases
  • 11.6. Uncommon Thoracic Tumors
  • Section 12. Lymphoid and Myeloid Neoplasia
  • 12.1. The Biology of Haemopoiesis
  • 12.2. Biology of Leukemia
  • 12.3. Acute Leukemia
  • (i). Acute Leukemia in Adults
  • (ii). Acute Leukemia in Childhood
  • 12.4. The Chronic Leukemias
  • 12.5. Bone Marrow Transplantation for Leukemia
  • 12.6. Autologous Bone-marrow Transplantation and Intensification Therapies for Solid Tumors and Lymphomas
  • 12.7. Hodgkin's Disease
  • (i). The Cell Biology of Hodgkin's Disease. V. Diehl, et al.
  • (ii). Hodgkin's Disease in Adults
  • (iii). Hodgkin's Disease in Childhood
  • 12.8. The Non-Hodgkin's Lymphoma
  • (i). The Pathology and Biology of Non-Hodgkin's Lymphoma
  • (ii). Non-Hodgkin's Lymphoma in Adults
  • (iii). The Non-Hodgkin's Lymphomas in Children
  • 12.9. Myeloma and Other Plasma Cell Malignancies
  • 12.10. Histiocyte Disorders
  • 12.11. Neoplastic Complications of AIIDS
  • Section 13. Bone Tumors and Soft Tissue Sarcomas
  • 13.1. Sarcoma of the Soft Tissue
  • 13.2. Malignant Mesenchymal Tumors in Childhood
  • 13.3. Ewing's Sarcoma
  • 13.4. Osteosarcoma
  • 13.5. Bone Malignant Tumors Other than Osteosarcoma and Ewing's Tumor
  • 14. Childhood Tumors
  • 14.1. The Molecular Pathology of Childhood Tumors
  • 14.2. Neuroblastoma
  • 14.3. Retinoblastoma
  • 14.4. Wilms' Tumor
  • 14.5. Germ Cell Tumors of Childhood
  • 14.6. Liver Tumors
  • 14.7. Rare Tumors of Childhood
  • Section 15. Tumors of the Central Nervous System
  • 15.1. Brain Tumors in Children
  • 15.2. Tumors of the Brain and Spinal Cord in Adults
  • Section 16. Endocrine Tumors
  • 16.1. Carcinomas of the Thyroid
  • 16.2. Medullary Carcinoma of the Thyroid
  • 16.3. Pituitary Tumors
  • 16.4. Adrenal Tumors
  • 16.5. Neuroendocrine Gastroenteropancreatic Tumors
  • Section 17. Tumors of Unknown Primary Site
  • Section 18. Cancer in the Elderly D. Raghavan
  • Section 19. Medical and Surgical Complications of Cancer
  • 19.1. Acute Emergencies in Oncology: General Overview
  • 19.2. Metabolic Disturbances
  • 19.3. Paraneoplastic Syndromes
  • 19.4. Immunological and Hematological Complications of Cancer
  • 19.5. Serous Effusions
  • 19.6. Spinal Metastatic Disease
  • 19.7. Pathological Fracture
  • 19.8. Complications Related to Radiotherapy
  • 19.9. Complications of Cytotoxic Therapy
  • 19.10. Effects of Cancer Chemotherapy on Fertility
  • 19.11. Tertogenic Effects of Cancer Treatment
  • 19.12. Carcinogenic Effects of Cancer Treatment
  • 19.13. Supportive Care, Antemetics, Alimentation
  • 19.14. Nutritional Support of Cancer Patients
  • Section 20. End-points Quality of Life
  • 20.1. Clinical Trial Methodology
  • 20.2. Data Management
  • 20.3. Quality of Life
  • 20.4. Psychological Sequelae of Cancer and its Treatment
  • 20.5. Pain Control and Palliation
  • 20.6. Rehabilitation of the Cancer Patient
  • 20.7. Care of the Dying Patient
  • 20.8. The Organization of Cancer Servies
  • 20.9. Economic Considerations in Cancer Care
  • 20.10. Cancer and Society: Health Education
  • 20.11. Support Systems for Cancer Patients